Company: KAVL
Filing Date: 2025-08-18
Form Type: 8-K
Source: 0001731122-25-001143
Chunk: 0

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On August 15, 2025, Kaival
Brands Innovations Group, Inc., a Delaware corporation, (the “ Company”), entered into an Equity Distribution Agreement (the
“ Agreement”) with Maxim Group LLC (“ Maxim”), as exclusive sales agent providing for the sale by the Company of
shares of its common stock, par value $0.001 per share (the “ Common Stock”), from time to time, i n
an “at the market offering” programthrough Maxim with certain limitations on the amount of Common Stock that
may be offered and sold by the Company as set forth in the Agreement (the “ Offering”). The
sales, if any, of the shares of Common Stock made under the Agreement will be made by any method permitted by law deemed to be an “at
the market offering” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the “ Securities Act”)
including sales made directly on or through the Nasdaq Capital Market or on any other existing trading market for the Company’s
common shares, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market
prices, and/or in any other method permitted by law.

The shares of
Common Stock, if any, will be issued pursuant to a prospectus supplement, dated August 15, 2025 (the “ Prospectus Supplement”),
and an accompanying base prospectus, dated August 8, 2025, contained therein, which together form a part of the Company’s “shelf”
registration statement on Form S-3 (File No. 333-288091) filed by the Company with the Securities and Exchange Commission (“ SEC”)
on June 16, 2025 and declared effective by the SEC on August 8, 2025. The aggregate market value of the shares of Common Stock eligible
for sale under the Prospectus Supplement is currently $1,553,536, which is based on the limitations of General Instruction I. B.6 of Form
S-3.

Under the Agreement, the Company will set the parameters
for the sale of shares, including the number of shares to be sold, the time period during which sales are requested to be made, limitation
on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the
terms and conditions of